2022 PTAB Year in Review (RECORDING)

Joshua Goldberg, leader of Finnegan’s PTAB trials section, focuses on inter partes review (IPR), covered business method (CBM), and post-grant review (PGR) proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), and on ensuing appeals to the U.S. Court of Appeals for the Federal Circuit.

Sydney Kestle focuses on several areas of patent law, including pre-litigation due diligence, client counseling, litigation in U.S. district courts, and proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO). Her patent practice covers several technology sectors in the mechanical and electrical arts, including industrial manufacturing, medical devices, and wireless communications and related consumer products. 

Gracie Mills is an associate with Finnegan where she focuses her practice on patent litigation before the Patent Trial and Appeal Board (PTAB), federal district courts, and the Court of Appeals for the Federal Circuit. Before the PTAB, she has experience representing both petitioners and patent owners, and she regularly navigates issues specific to the interplay between PTAB and federal district court litigation.

Trenton Ward is a partner and patent litigator at Finnegan. Ward joined Finnegan in 2017 from the PTAB where he spent three years as a Lead Administrative Patent Judge. He served on panels for more than 275 Decisions on Institution and Final Written Decisions, authoring many. Trenton assisted the Chief Judge in formulating and executing policy for AIA trials and PTAB operations. Earlier he worked as an electrical engineer. 

Tom Irving is a partner with Finnegan. He has more than 40 years of experience in the field of intellectual property law. His practice includes America Invents Act (AIA) post-grant proceedings, due diligence, counseling, patent prosecution, and reissue and reexamination. He counsels clients on a wide range of mainly pharmaceutical matters, including pre-litigation, Orange Book listings of patents covering FDA-approved drugs, infringement issues, enforceability and validity analysis.